Clinical Trial Update: The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the safety and efficacy of etanercept in psoriasis patients unresponsive to adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Dermatrials Research | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED